Half-truths and selective memory: Interferon gamma, CD4(+) T cells and protective memory against tuberculosis

Area of Science:

• Immunology
• Vaccinology
• Microbial Pathogenesis

Background:

• Developing an effective tuberculosis vaccine is hindered by incomplete understanding of protective memory immune responses.
• Interferon gamma (IFN-γ) production by CD4(+) T cells is a commonly used, yet often unreliable, surrogate for protective memory immunity against tuberculosis.
• The predictive value of IFN-γ may be limited due to differing requirements for protection during primary versus memory recall immune responses.

Purpose of the Study:

• To review the current understanding of protective memory immune responses against tuberculosis.
• To challenge the reliance on IFN-γ as the sole marker of protective memory immunity.
• To explore alternative mechanisms, such as IL-17 and regulatory T cells, involved in memory CD4(+) T cell-mediated protection.

Main Methods:

• Literature review of immunological studies on tuberculosis.
• Analysis of evidence regarding CD4(+) T cell responses and their role in primary and memory immunity.
• Discussion of potential alternative immune mediators and cell types.

Main Results:

• Evidence suggests that memory CD4(+) T cells can confer protection against tuberculosis independently of IFN-γ.
• The role of IFN-γ in protection may differ significantly between the initial infection response and the memory recall response.
• Interleukin-17 (IL-17) and regulatory T cells are proposed as potential alternative mechanisms for protective immunity.

Conclusions:

• A comprehensive understanding of protective memory immunity is essential for effective tuberculosis vaccine development.
• Relying solely on IFN-γ production as a correlate of protection may be insufficient.
• Further research into alternative immune pathways, including IL-17 and regulatory T cells, is warranted for advancing tuberculosis vaccine strategies.